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Background: The increasing number of babies conceived by in vitro fertilization and embryo transfer (IVF-ET) shifts
concern from pregnancy outcomes to long-time health of offspring. Maternal high estradiol (E2) is a major characteristic
of IVF-ET and lasts throughout the first trimester of pregnancy. The fetal thyroid develops during this period and may
thus be affected by exposure to the supra-physiological E2. The aim of this study is to investigate whether the high E2
maternal environment in the first trimester increases the risk of thyroid dysfunction in children born following IVF-ET.
Methods: A cross-sectional survey design was used to carry out face-to-face interviews with consecutive children
attending the hospital. A total of 949 singletons born after fresh embryo transfer (ET) (n = 357), frozen ET (n = 212),
and natural conception (NC) (n = 380), aged 3 to 10 years old, were included. All children were thoroughly examined.
Meanwhile, another 183 newborns, including 55 fresh ET, 48 frozen ET, and 80 NC were studied. Levels of serum T3,
FT3, T4, FT4, and TSH and levels of maternal E2 at different stages of the first trimester were examined.
Results: The mean serum E2 levels of women undergoing fresh ET during the first trimester of pregnancy were
significantly higher than those of the women undergoing frozen ET or following NC. The thyroid hormone profile,
especially the levels of T4, FT4, and TSH, were significantly increased in 3- to 10-year-old children conceived by fresh
ET compared to NC. The same tendency was confirmed in newborns. However, levels of T4 and TSH in the frozen ET
group were nearer to that of the NC group. Furthermore, levels of T4 and FT4 in fresh ET were positively correlated with
maternal serum levels of E2 during early pregnancy.
Conclusions: The maternal high E2 environment in the first trimester is correlated with increased risk of thyroid
dysfunction. Frozen ET could reduce risks of thyroid damage in children conceived by IVF. Further studies are needed
to confirm these findings and to better determine the underlying molecular mechanisms and clinical significance.
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Assisted reproduction technology (ART) has been applied
for treating infertility for more than three decades since
the first successful case by Steptoe in 1978 [1]. Up to now,
there are over five million children in the world who were
born following in vitro fertilization (IVF) and embryo
transfer (ET). The increasing number of IVF babies shifts
concern from pregnancy outcomes to the long-term
health of IVF offspring. It is reported that babies
conceived through ART are at increased risks of low
birth weight and being small for their gestational age,
which are themselves associated with increased risks of
adult diseases including diabetes mellitus and cardio-
vascular diseases [2-6]. However, observational studies
have not shown any significant difference in neuron
developmental outcomes with conflicting results regarding
the presence of cerebral palsy [7]. Interestingly, thyroid
function studies in IVF children have been quite limited.
The early occurrence of thyroid dysfunction, if not
promptly treated, causes serious and irreversible dam-
age to the central nervous system with subsequent
mental impairment and may predispose to cardiovascular
disease in the long-term [8,9]. Additionally, emerging
studies suggest that the pre-implantation period is vulner-
able to epigenetic perturbations and call for systematic
long-term follow-up of IVF children [10].
In fresh ET cycles, controlled ovarian hyperstimulation
(COH) of ART situates the gamete/embryo in a supra
physiological estradiol (E2) environment, and there is
further evidence that E2 may influence thyroid functions
[11-14]. In our previous study, we found that increased
E2 concentrations after COH not only appeared before
and during implantation but also after implantation; this
is an effect which could last throughout the first trimes-
ter [3]. Since the abnormal endocrine environment of
increased E2 after COH could persist to first trimester of
pregnancy, fetal development during this period may be
impaired. This is likely to be the case for hormone-
sensitive organs such as the thyroid gland which is the
first endocrine gland to differentiate in the early embryo
at approximately 3 to 5 weeks gestation [15]. As one of
the largest endocrine glands, the primary function of
the thyroid gland is to synthesize thyroid hormones by
metabolizing iodide. Thyroid hormones are critical regula-
tors of growth, development, and metabolism in almost
all tissues. However, few studies have investigated the
thyroid function of children conceived through IVF and
therefore long-term monitoring of their thyroidal status
is needed [16].
The aim of this study is to investigate possible thyroid
dysfunction in fresh ET children compared with natural
conception (NC) and to evaluate whether the high E2
environment during early pregnancy was causative.
Because frozen ET is performed in the natural cyclewith a normal intrauterine environment, we studied 212
children conceived after frozen ET and investigated
whether avoiding the exposure to high E2 environment
during the first trimester could reduce the risk of thyroid
dysfunction. Additionally, we collected umbilical cord
blood of newborns conceived by fresh ET, frozen ET, and
NC and analyzed whether the levels of thyroid hormones
correlated with maternal serum E2 levels during early
pregnancy in the fresh ET group.
Methods
Study cohort
A cross-sectional survey was undertaken at the ART Unit
in the Women’s Hospital, School of Medicine, Zhejiang
University, China. The study was approved by the Ethical
Committee of Women’s Hospital, School of Medicine,
Zhejiang University and was registered in the Chinese
Clinical Trial Registry (ChicCTR-OCC-14004682). The
ART unit is one of the earliest licensed by the Health
Ministry of People’s Republic of China and is also one of
the largest in the country. A total of 949 Asian singletons
aged 3 to 10 years old delivered from January 2003 to
March 2011 were included in this study of which 357
cases were after fresh ET, 212 cases after frozen ET,
and 380 after NC. Face-to-face interviews were carried
out and the children were examined thoroughly. Inter-
views took place in the visit room individually and lasted
approximately 30 minutes. Written consent was obtained
in every case prior to assessment.
All NC cases were randomly selected and matched
for age and gender to cases in the fresh ET group and
frozen ET group. These patients had been referred to
the Physical Examination Center for a regular health
examination and were recruited when they agreed to
participate. All cases were healthy, did not take any
medication, and lived in iodine-replete areas. None of
the NCs had congenital hypothyroidism. Mothers with
thyroiditis, hyperthyroidism, or hypothyroidism during
pregnancy were excluded.
Additionally, we studied 183 full-term singleton infants,
including 55 fresh ET, 48 frozen ET, and 80 NC born in
our hospital. They were matched according to maternal
age, gestational age, and birth weight and all IVF babies
were conceived after traditional IVF, whereas infants
conceived after intracytoplasmic sperm injection were ex-
cluded. All newborns selected above were free of obstetric
complications during pregnancy such as pregnancy-induced
hypertension, gestational diabetes mellitus, placenta pre-
via, and intrahepatic cholestasis. Mothers with thyroiditis,
hyperthyroidism, or hypothyroidism during pregnancy
were also excluded.
During all the fresh ET cycles, ovarian stimulations
were performed by the standard long or short protocols
as previously described [17]. Oocyte retrieval was carried
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were performed on Day 2 or Day 3. Cryopreserved embryos
were thawed on the day of the transfer and all the
frozen ETs proceeded in natural cycles without COH.
Children and babies from the fresh or frozen ET groups
were excluded if the women had received donated oocytes
or sperm, or if they had undergone pre-implantation
genetic diagnosis.
On the other hand, maternal serum E2 levels on hCG
administration day of 55 fresh ET newborns were obtained
from database of the hospital. In order to detect the mater-
nal E2 level, blood samples of another 530 women with
singleton conceptions at 4 to 12 weeks of gestation were
obtained from October 2012 to June 2013, including 206
fresh ET, 124 frozen ET, and 200 NC and their clinical
gestational data were also obtained from the database.
History records and physical examination
A detailed medical history was obtained from all partici-
pants. Data recorded included the maternal age, sex, ART
methods, infant birth weight, birth length, gestational
age, and mode of feeding. Gestational age was calculated
based from the date of ET and the date of birth. The same
trained female nurse examined all children. Physical
examination included height, weight, body mass index,
systolic blood pressure, diastolic blood pressure, and heart
rate. We had access to complete clinical data for each
individual.
Serum levels of thyroid hormones in children and newborns
Samples were collected from umbilical cord blood of
newborns at birth and peripheral blood of 3- to 10-year-
old children at 8:00 am after overnight fasting. Serum
T3, FT3, T4, FT4, and TSH were assayed with the
Abbott Architect i2000 assay (Abbot Diagnostics) in the
local laboratory. The intra- and inter-assay coefficients
of variation for the determination of all biochemical
variables were less than 5%.
Correlation analysis of maternal serum E2 levels with
thyroid hormones of offspring
Characteristics and cycle parameters of patients were
obtained from databases of the Department of Repro-
ductive Endocrinology, Women’s Hospital, School of
Medicine, Zhejiang University. To explore the correl-
ation between maternal E2 level and thyroid hormones
in offspring, we analyzed serum levels of T4 and FT4 of
55 fresh ET newborns and gestational E2 levels on the
day that their mothers received hCG.
Statistical analysis
Either the two-tailed Student’s t-test or ANOVA were used
to evaluate continuous parametric data. Relationships
between type of conception and thyroid function wasanalyzed by a regression model with adjustment for age
of child, type of assisted reproduction, and sex of child
or maternal variables (pregnancy-induced hypertension,
gestational diabetes mellitus, placenta previa, or intra-
hepatic cholestasis); the χ2 test was used to compare
categorical data. Pearson’s correlation coefficient was
applied to explore the association of T4 and FT4 with
E2 levels. Log transformations were conducted when
the normality assumption was not satisfied. Analyses
were conducted using SPSS statistical software (version
16.0) and P <0.05 indicated statistical significance.Results
Characteristics
Table 1 presents physical examination and medical history
characteristics of children conceived by fresh ET, frozen
ET, and NC. All groups were similar according to age,
gender, birth length, mode of feeding, current weight/
length, rate of preterm delivery, blood pressure, heart rate,
and maternal age. Children conceived by fresh ET had sig-
nificantly lower gestational age and birth weight compared
with NC, whereas no statistically significant differences
were observed between frozen ET and NC. Maternal age
in the NC group was significantly lower than in the fresh
ET and frozen ET groups. Table 2 presents the physical
examination and medical history characteristics of new-
borns born after fresh ET, frozen ET, and NC. All groups
were similar according to gender, birth weight/length, ges-
tational age, and maternal age.Maternal serum levels of E2 during the first trimester after
fresh ET, frozen ET, and NC
The most critical period of fetal thyroid development is
the first trimester of pregnancy (Figure 1A). We analyzed
the maternal serum levels of E2 during the first trimester
in 206 patients after fresh ET, 124 patients after frozen ET,
and 200 after NC (Figure 1B). In addition to the much
higher level of E2 upon hCG administration, the mean
levels of serum E2 of mothers in the fresh ET group were
4,351.3 ± 250.4 pmol/L at 4 weeks, 6,027.7 ± 529.7 pmol/L
at 5 to 7 weeks, 7,305.2 ± 420.1 pmol/L at 8 weeks, and
9,691.9 ± 903.7 pmol/L at 9 to 12 weeks of gestation,
which were all significantly higher than those in the frozen
ET group (1,586.2 ± 126.9 pmol/L at 4 weeks, 3,020.3 ±
227.7 pmol/L at 5 to 7 weeks, 4,168.1 ± 238.1 pmol/L at
8 weeks, and 6,748.0 ± 482.2 pmol/L at 9 to 12 weeks,
P <0.01, respectively), and those in NC group (1,427.9 ±
63.4 pmol/L at 4 weeks, 2,911.5 ± 249.4 pmol/l at 5 to
7 weeks, 3,968.3 ± 151.1 pmol/L at 8 weeks, and 6,310.5 ±
309.7 pmol/L at 9 to 12 weeks, P <0.01, respectively,
Figure 1B). There was no significant difference between
E2 levels in the frozen ET and NC groups during the
first trimester (Figure 1B).
Table 1 Physical examination characteristics and medical history of children conceived by natural conception (NC),
fresh embryo transfer (ET), and frozen ET
NC Fresh ET Frozen ET P value P value P value
(n = 380) (n = 357) (n = 212) (Fresh ET vs. NC) (Fresh ET vs.
Frozen ET)
(Frozen ET vs. NC)
Age (yr) 4.98 ± 1.47 5.01 ± 1.12 4.96 ± 1.01 NS NS NS
Gender, n (%) Boy 194 (51.1%) 186 (52.1%) 95 (44.8%) NS NS NS
Girl 186 (48.9%) 171 (47.9%) 117 (55.2%)
Birth weight (g) 3376 ± 381 3307 ± 526 3322 ± 553 <0.05 NS NS
Birth length (cm) 50.07 ± 0.95 49.93 ± 2.27 49.80 ± 2.70 NS NS NS
Gestational age (wk) 38.76 ± 1.63 38.32 ± 1.70 38.48 ± 1.58 <0.01 NS <0.05
BMI 15.49 ± 1.44 15.28 ± 1.68 15.47 ± 1.72 NS NS NS
Weight (kg) 19.29 ± 3.57 19.22 ± 4.26 19.03 ± 4.03 NS NS NS
Length (cm) 111.19 ± 8.47 111.67 ± 8.25 110.28 ± 8.66 NS NS NS
Preterm delivery No 350 (92.1%) 318 (89.1%) 187 (88.2%) NS NS NS
(<37 wk), n (%) Yes 30 (7.9%) 39 (10.9%) 25 (11.8%)
ART method IVF / 252 (70.6%) 152 (71.7%) NA NS NA
ICSI / 105 (29.4%) 60 (28.3%)
Mode of feeding Breast 207 (54.4%) 197 (55.2%) 115 (54.2%) NS NS NS
Artificial 80 (21.1%) 66 (18.5%) 52 (24.5%)
Mixed 93 (24.5%) 94 (26.3%) 45 (21.3%)
Blood pressure (mmHg) SBP 97.86 ± 14.09 97.71 ± 16.19 97.35 ± 16.59 NS NS NS
DBP 56.56 ± 9.05 55.77 ± 11.42 56.35 ± 11.38 NS NS NS
Heart rate (bpm) 96.94 ± 12.52 96.26 ± 13.76 97.44 ± 12.64 NS NS NS
Maternal age (yr) 29.69 ± 3.63 31.05 ± 3.70 31.35 ± 3.66 <0.01 NS <0.01
Pregnancy complications, n (%)
Gestational diabetes 12 (3.2%) 12 (3.4%) 11 (5.2%) NS NS NS
Intrahepatic cholestasis 8 (2.1%) 5 (1.4%) 2 (0.9%) NS NS NS
Pre-eclampsia 8 (2.1%) 13 (3.6%) 3 (1.4%) NS NS NS
Placenta previa 14 (3.7%) 12 (3.4%) 5 (2.4%) NS NS NS
Data are presented as mean ± SD or n (%), NS, not significant; NA, Not applicable; ART, Assisted reproduction technology; BMI, Body mass index; DBP, Diastolic
blood pressure; IVF, In vitro fertilization; ICSI, Intracytoplasmic sperm injection; SBP, Systolic blood pressure.
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We compared the serum levels of thyroid hormone
profile between children conceived by fresh ET, frozen
ET, and NC. Except for gestational age, birth weight,
and maternal age, there were no significant differences
in physical examination characteristics and medical
history among the NC, fresh ET, and frozen ET groups
(Table 1). Interestingly, in 3- to 10-year-old children
conceived by fresh ET, the levels of T4, FT4, and TSH
were significantly higher than those of children conceived
by NC (crude P <0.01, Table 3). Although there was no
significant difference, the levels of T3 and FT3 tended
to be higher in the fresh ET group. The observation
that frozen ET can avoid exposure to high maternal E2
environment in IVF led us to compare the thyroidhormone profiles between the children conceived by
fresh ET and frozen ET. We found that levels of T4 and
TSH in the frozen ET group were significantly lower
(crude P <0.01, Table 3) and nearer to the values of the
NC group. In order to solidify the results, we further
analyzed the relationship between type of conception
and thyroid function with adjustment for age of child,
ART type, and sex of child or maternal variables (preg-
nancy-induced hypertension, gestational diabetes mellitus,
placenta previa, or intrahepatic cholestasis) by a regres-
sion model adjusting. We found that levels of T4, FT4,
and TSH were still significantly higher than those of
children conceived by NC (Adjusted P <0.01, Table 3).
However, the levels of T4 and TSH in the frozen ET
group were significantly lower than fresh ET (Adjusted
P <0.01, Table 3).
Table 2 Physical examination characteristics and medical history of newborns conceived by natural conception (NC),
fresh embryo transfer (ET), and frozen ET
NC Fresh ET Frozen ET P value P value P value
(n = 80) (n = 55) (n = 48) (Fresh ET vs. NC) (Fresh ET vs. Frozen ET) (Frozen ET vs. NC)
Singletons/Twins Singletons Singletons Singletons NS NS NS
Gender, n (%) Boy 41 (51.3%) 27 (49.1%) 23 (47.9%) NS NS NS
Girl 39 (48.7%) 28 (50.9%) 25 (52.1%)
Birth weight (g) 3411 ± 305 3385 ± 488 3404 ± 389 NS NS NS
Birth length (cm) 50.03 ± 0.83 49.72 ± 0.81 49.91 ± 0.72 NS NS NS
Gestational age (wk) 38.63 ± 0.95 38.37 ± 0.91 38.44 ± 1.04 NS NS NS
Preterm delivery (<37 wk), n (%) No 80 (100%) 55 (100%) 48 (100%) NS NS NS
Yes 0 (0%) 0 (0%) 0 (0%)
ART method IVF / 55 (100%) 48 (100%) NA NS NA
ICSI / 0 (0%) 0 (0%)
Maternal age (yr) 30.53 ± 3.17 31.31 ± 3.07 31.73 ± 3.83 NS NS NS
Pregnancy complications, n (%) 0 0 0 NS NS NS
Data are presented as mean ± SD or n (%), NS, not significant; NA, Not applicable. ART, Assisted reproduction technology; BMI, Body mass index; IVF, In vitro
fertilization; ICSI, Intracytoplasmic sperm injection.
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by fresh ET
We further calculated and compared the rate of 3- to
10-year-old children whose serum T4, FT4, or TSH levels
were beyond the standard values. Two out of 357 children
conceived by fresh ET (0.6%) were found to have T4 levels
exceeding 150.84 nmol/L, while none was detected in the
NC group. FT4 exceeding 19.05 pmol/L was present in 26
of 357 children conceived by fresh ET (7.3%) and in none
in the NC group (P <0.01, Table 4). TSH exceeding 5.05
mIU/L was present in 22 of 357 children conceived by
fresh ET (6.2%) and in 3 of 380 of the NC group (0.08%)
(P <0.01, Table 4). Further, one child showed both elevated
FT4 (>19.05 nmol/L) and TSH (>5.05 mIU/L) in the fresh
ET group, whereas none did so in either the frozen ET or
NC groups. Interestingly, no significant difference was
found between serum TSH levels in the 3- to 10-year-old
children conceived by frozen ET and those by NC (2.4%
vs. 0.08%). Although the incidence of elevated FT4 in the
frozen ET group (4.7%) was still significantly higher than
that of the NC group (P <0.01, Table 4), compared to
fresh ET, a decreased tendency of risk was observed in
the frozen ET group.
Umbilical levels of thyroid hormones and TSH in
newborns born after fresh ET and NC
Additionally, we examined the levels of T4, FT4, T3, FT3,
and TSH in umbilical blood in 183 newborns, including
55 fresh ET cases, 48 frozen ET cases, and 80 NC cases.
There were no significant differences in physical examin-
ation characteristics and medical history among the three
groups (Table 2). Surprisingly, in newborns conceived by
fresh ET, the levels of T4, FT4, and TSH were significantlyhigher than those of children conceived by NC (crude
P <0.01, P <0.05, and P <0.01, respectively, Table 5).
However, the levels of T4 and TSH in the frozen ET
group were significantly lower than in the fresh ET
group (crude P <0.05, Table 5), which were similar to
values in the NC group. No significant differences in
the levels of T3 and FT3 were found among the three
groups (crude P >0.05, respectively). Moreover, we
further analyzed the relationship between type of con-
ception and thyroid function with adjustment for sex.
We found that levels of T4, FT4, and TSH were also
significantly higher than those in newborns conceived
by NC (Adjusted P <0.01, P <0.05, and P <0.05, respect-
ively, Table 5). However, levels of T4 and TSH in the
frozen ET group were significantly lower compared
with fresh ET (Adjusted P <0.05, Table 5). There was
no significant difference between frozen ET and NC.Maternal serum E2 levels on the hCG administration day
positively correlated with levels of T4/FT4 in newborns
conceived by fresh ET
To further explore the relationship between maternal
serum E2 levels and the thyroid hormone profile, a total
cohort of 55 newborn singletons born after fresh ET and
their mothers were investigated further. We examined
the serum E2 levels on the day of hCG administration in
these patients. We adopted bivariate correlation analysis
to investigate the correlation between thyroid hormones
and E2, and found that the maternal serum E2 levels on
the day of hCG administration positively correlated with
levels of T4 and FT4 of their offspring (r = 0.52, P < 0.01
and r = 0.47, P < 0.01, respectively; Figure 2A,B).
AB
Figure 1 Schematic view of thyroid morphogenesis and maternal
serum estradiol levels during early pregnancy. (A) Schematic view
of thyroid morphogenesis in human development. The thyroid gland
begins to develop at 3 to 5 weeks of gestation as an endodermal
thickening in the floor of the primitive pharynx. From week 5, thyroid
precursor cells express a combination of transcription factors which are
required for the early stages of thyroid development. After losing all
connections with the pharynx, the thyroid bud migrates caudally,
reaching its final position in front of the trachea at 6 weeks. Thyroid
follicular cells begin their differentiation program and express
thyroid-specific genes and secrete thyroid hormones from week 7.
Finally, primitive follicles appear and the gland displays its final
morphological organization (8 to 12 weeks) [12]. (B) Maternal serum
estradiol concentrations during the first trimester of pregnancy. The
mean serum levels of estradiol (E2) in the fresh embryo transfer (ET)
group (n = 206) at different stages were all significantly higher than
those in the frozen ET (n = 124) and natural conception (NC) (n = 200)
groups during the first trimester of pregnancy. Data are presented as
mean ± SEM, **P <0.01 vs. NC, ##P <0.01 vs. frozen ET. ET day, day of
embryo transfer; hCG day, day of hCG administration.
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Evidence has indicated that an adverse intrauterine en-
vironment influences fetal growth and health [3-6,18].
Maternal undernutrition during pregnancy could induce
low birth weight, impaired glucose tolerance, and obesity
in offspring [19-21]. Intrauterine exposure to diabetes is
associated with increased risk of abnormal glucose
homeostasis in offspring beyond that attributable togenetic factors [22,23]. In a previous study, we found
that a high E2 environment is correlated with an increased
risk of low birth weight and small-for-gestational age size,
which may lead to chronic diseases in later life. COH
results in increased E2 concentrations not only before and
during implantation, but also after implantation, which
lasts throughout the first trimester [3]. It is suggested that
besides birth weight, the abnormal maternal endocrine
environment may also affect the fetal system developed
during the first trimester after fresh ET. In our study, we
analyzed maternal serum levels of E2 at different stages
during the first trimester and found the maintenance of
a high level of E2 in the fresh ET group. In contrast, the
level of E2 in the frozen ET group was similar to that of
the NC group.
The thyroid is one of the earliest endocrine glands to
develop in the fetus [15,24] and E2 may influence thyroid
functions [11,13,14]. In our present work, we investigated
the thyroid hormone profile of 3- to 10-year-old single-
tons conceived by fresh ET, frozen ET, and NC. We found
that the levels of T4 and FT4 were both significantly
higher in the fresh ET group than in the NC and frozen
ET groups. The levels of T3 and FT3 also showed an
increased tendency in the fresh ET group, although with
no significant difference. Moreover, the percentage of
3- to 10-year-old children whose serum FT4 or TSH levels
were beyond the standard value were significantly increased
in the fresh ET group, demonstrating the increased risk of
thyroid disease in children conceived by fresh ET. Accord-
ing to the hypothalamus-pituitary-thyroid (HPT) feedback
loop, elevated T4/FT4 is always accompanied by sup-
pressed TSH [25]. However, at the same time, compared
to NC, we found that both TSH and T4/FT4 concen-
trations increased significantly in the fresh ET group,
probably since, in 3- to 10-year-old children, the HTP
axis is gradually establishing and improving, and the
feedback mechanism is not an exact response [26]. Actu-
ally, some children showed elevated T4 and/or FT4 and
some showed elevated TSH alone, whereas some showed
elevated FT4 and TSH. Except for an immature HTP axis,
since early pregnancy is also an important period for
neural system development [27,28], the high E2 environ-
ment maybe also attenuate hypothalamus and/or pituitary
functions, inducing a disordered hormone secretion.
The IVF-ET is a complicated process including COH,
IVF, in vitro culture, and related processes. The most
critical difference between fresh ET and frozen ET is the
high E2 environment during early pregnancy. As expected,
the incidence of children with elevated TSH in the frozen
ET group was significantly lower than that of the fresh ET
group, indicating that the risk was obviously reduced
when the high estradiol environment during early preg-
nancy was relieved. However, FT4 in the frozen ET group
ranged between NC and fresh ET groups. The explanation
Table 3 The levels of thyroid hormone profile in children conceived by natural conception (NC), fresh embryo transfer
(ET), and frozen ET
NC Fresh ET Frozen ET Fresh ET vs.
NC Crude P




(n = 380) (n = 357) (n = 212) (Adjusted P) (Adjusted P) (Adjusted P)
T3 (nmol/L) 2.28 ± 0.22 2.31 ± 0.32 2.31 ± 0.41 0.06 (0.09) 0.78 (0.77) 0.25 (0.32)
FT3 (pmol/L) 5.92 ± 0.61 6.01 ± 0.73 5.98 ± 0.91 0.07 (0.07) 0.65 (0.83) 0.36 (0.20)
T4 (nmol/L) 100.1 ± 17.06 105.81 ± 16.82 100.76 ± 15.75 <0.01 (<0.01) <0.01 (<0.01) 0.64 (0.91)
FT4 (pmol/L) 15.76 ± 1.67 16.55 ± 1.74 16.46 ± 1.61 <0.01 (<0.01) 0.54 (0.69) <0.01 (<0.01)
TSH (mIU/L) 2.35 ± 0.96 2.69 ± 1.37 2.41 ± 0.98 <0.01 (<0.01) <0.01 (<0.01) 0.49 (0.51)
Data are shown as mean ± SD.
Log transformations were conducted when the normality assumption was not satisfied. Adjusted P values were calculated by linear regression adjusted for age of
child, type of assisted reproduction, sex of child, or maternal variables (obstetric complications).
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intrauterine development, gametes and zygotes/embryos
are also exposed to a series of non-physiological processes,
especially a high E2 environment and culture media
[29-31]. The adverse effects of IVF treatment on germ
lines and embryos may also cause fetal thyroid damage.
In order to explore whether intrauterine exposure to a
high E2 environment could alter the thyroid function of
offspring as early as birth, we further examined the
thyroid hormone profile in newborns of fresh ET, frozen
ET, and NC. There was no significant difference in birth
weight and other physical characteristics among three
groups. It is noteworthy that the significantly elevated
levels of T4, FT4, and TSH not only existed in 3- to 10-
year-old children, but were also observed in newborns.
Previously, we have confirmed the serum E2 level on the
hCG administration day is an effective marker reflecting
the E2 level during early pregnancy [3]. We analyzed the
association between maternal E2 at hCG day and T4/FT4
in newborns conceived by fresh ET, finding a positive
correlation. The results demonstrated that early exposure
to a high maternal E2 environment is directly responsible
for hyperactive fetal thyroid function, which persists
throughout childhood.
Sakka et al. studied a total of 106 children conceived
after classic IVF and 68 naturally conceived controls,
aged 4 to 14 years old, and found that 7 IVF children
but none of the controls had persistent elevations of
circulating TSH. They also found the level of TSH was
significantly higher in the IVF group than in controls,Table 4 The incidence of 3- to 10-year-old children whose ser
in natural conception (NC), fresh embryo transfer (ET), and fr
NC Fresh ET Frozen ET
(n = 380) (n = 357) (n = 212)
T4 >150.84 (nmol/L) 0 (0%) 2 (0.6%) 0 (0%)
FT4 >19.05 (pmol/L) 0 (0%) 26 (7.3%) 10 (4.7%)
TSH >5.05 (mIU/L) 3 (0.08%) 22 (6.2%) 5 (2.4%)
Data are shown as n (%). NA, Not applicable.which is consistent with our results, whereas no signifi-
cant differences in the concentrations of T3 or T4 were
observed in their study [16]. In our study, we enlarged the
number and added the detection of frozen ET children as
well as newborns, indicating that the thyroid hormone
profile altered as early as birth and that frozen ET could
reduce the risks of thyroid damage in children conceived
by ET due to a normal intrauterine environment.
Thyroid hormones play an important role in regulating
lipid metabolism and thyroid dysfunction can result in
lipid abnormalities which increase the risk of hypertension,
cardiovascular disease, and endothelial dysfunction [32].
The increased cardiovascular risk in thyroid dysfunction is
related to lipid profile, endothelial dysfunction, metabolic,
hormonal, and hemodynamic changes, and coagulation
disturbances [9]. Caraccio et al. reported that subclinical
hypothyroidism adversely affected some surrogate markers
for cardiovascular disease [33]. Moreover, a previous study
reported that mental changes were always accompanied
with thyroid dysfunction, perhaps due to stimulation by
the protean actions of the thyroid hormone and thyroid
gland playing a role in the pathogenesis of psychiatric
disorders [8]. Accumulating studies showed that IVF
children manifested significant increases of arterial blood
pressure and adipose tissue distribution as well as a higher
level of fasting blood glucose [34,35]. In addition, recent
studies in IVF-conceived mice have displayed increased
fasting glucose and impaired glucose tolerance [2]. These
cardiometabolic alterations and lipid metabolic disorder
in IVF children might be partly attributed to a higherum level of T4, FT4, or TSH beyond the standard values
ozen ET groups
Fresh ET vs. NC Fresh ET vs. Frozen ET Frozen ET vs. NC




Table 5 The levels of thyroid hormone profiles in newborns conceived by natural conception (NC), fresh embryo
transfer (ET), and frozen ET
NC Fresh ET Frozen ET Fresh ET vs. NC Fresh ET vs. Frozen ET Frozen ET vs. NC
(n = 80) (n = 55) (n = 48) Crude P Crude P Crude P
(Adjusted P) (Adjusted P) (Adjusted P)
T3 (nmol/L) 2.09 ± 0.44 2.13 ± 0.47 1.94 ± 0.65 0.60 (0.66) 0.09 (0.09) 0.18 (0.10)
FT3 (pmol/L) 4.93 ± 0.92 5.07 ± 1.25 5.02 ± 1.57 0.43 (0.43) 0.85 (0.84) 0.52 (0.67)
T4 (nmol/L) 98.41 ± 14.71 107.65 ± 18.93 99.69 ± 21.43 <0.01 (<0.01) 0.03 (0.03) 0.69 (0.73)
FT4 (pmol/L) 15.66 ± 1.97 16.50 ± 1.76 16.39 ± 2.47 0.01 (0.01) 0.82 (0.82) 0.04 (0.07)
TSH (mIU/L) 2.69 ± 0.99 3.15 ± 1.01 2.76 ± 1.00 <0.01 (0.01) 0.03 (0.03) 0.91 (0.78)
Data are shown as mean ± SD.
Log transformations were conducted when the normality assumption was not satisfied. Adjusted P values were calculated by linear regression adjusted for sex
of newborn.
Lv et al. BMC Medicine  (2014) 12:240 Page 8 of 10occurrence of thyroid dysfunction. Therefore, early occur-
rence of thyroid dysfunction, if not promptly treated,
will cause serious and irreversible damage to the cardio-
vascular system and predisposes to dyslipidemia, mental
changes, and metabolic disorders later in life.
A plausible explanation for the abnormal thyroid hor-
mone profile among children conceived by fresh ET is
the possible epigenetic alterations that might occur
during early pregnancy after exposure to a high E2 envir-
onment. There is now substantial evidence suggesting
that ART pregnancies are associated with altered outcomes
in fetal and neonatal development, mainly due to epigenetic
modifications of gene expression [36-39]. The fetal thyroid
develops during the first trimester of pregnancy and may
be affected by exposure to supra-physiological E2. Some
previous reports have indicated that E2 might regulate
thyroid function through a direct action on the thyrocytes
[40-42]. Antico-Arciuch et al. proved that E2 is directly
responsible for the increased susceptibility to thyroid dis-
ease on activation of the PI3K pathway [43]. Additionally,
E2 effects on thyroid iodide uptake and thyroperoxidaseR=0.52, P<0.01
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Figure 2 Correlation between maternal serum E2 levels at HCG day a
maternal serum E2 concentrations on the hCG administration day positively
conceived by fresh ET (r = 0.52, P <0.01, n = 55 and r = 0.35, P <0.01, n = 55activity have been confirmed in animal studies [44].
Ho et al. found permanent alterations in the DNA
methylation patterns of multiple cell signaling genes
after transient developmental exposure to E2, suggesting
an epigenetic basis for estrogen imprinting [45]. Thus,
the altered thyroid hormone profile observed in fresh
ET offspring, may be the result of epigenetic alteration
in the set point of thyroid hormone sensitivity induced
by the high E2 environment.
Conclusions
Our results demonstrate that T4, FT4, and TSH levels
were significantly increased in newborns as well as in
children aged 3 to 10 years old conceived by fresh ET
compared to NC. A remarkably higher maternal E2 level
was maintained in the fresh ET group during early preg-
nancy and was positively correlated with the increased
levels of T4 and FT4. Frozen-thawed ET, conducted in the
normal conception cycles to avoid the high E2 environ-
ment during the first trimester, could reduce the risk of
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nd T4/FT4 levels in fresh embryo transfer (ET) offspring. The log of
correlated with the serum levels of (A) T4 and (B) FT4 in newborns
, respectively).
Lv et al. BMC Medicine  (2014) 12:240 Page 9 of 10observations suggest that a high E2 environment during
the first trimester is directly responsible for the altered
thyroid hormone profile in offspring conceived by fresh
ET and evaluation of serum E2 before ET should be
adopted to reduce the possibility of high E2 exposure to
the developing embryo. Our findings provide new insights
into the safety of IVF children and underline the import-
ance of continuous monitoring of endocrine axes of IVF
children. Further studies are needed to confirm these find-
ings and to better determine their etiopathogenesis and
clinical significance.
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